Current Brachytherapy News and Events | Page 3

Current Brachytherapy News and Events, Brachytherapy News Articles.
Sort By: Most Relevant | Most Viewed
Page 3 of 6 | 224 Results
The 31st ESTRO Conference and the World Congress of Brachytherapy
ESTRO 31 and the World Congress of Brachytherapy will combine to feature new research results in clinical and basic radiobiology, physics and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients. The two conferences, which will run in parallel, are expected to attract 6,000 delegates from around 50 countries. (2012-04-18)

An invitation to Europe's largest forum on radiation oncology
ESTRO 31 and the World Congress of Brachytherapy will combine to feature new research results in clinical and basic radiobiology, physics and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients. (2012-04-04)

Brachytherapy reduced death rates in high-risk prostate cancer patients, study finds
A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy had significantly reduced mortality rates. (2012-01-25)

Proton therapy effective prostate cancer treatment
Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal of Radiation Oncology•Biology•Physics, the American Society for Radiation Oncology's official scientific journal. (2012-01-05)

Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy
Accelerated partial breast irradiation using brachytherapy for the treatment of breast cancer has been rapidly increasing over the last several years in the US as an alternative to standard whole-breast irradiation, according to a study published Dec. 16 in the Journal of the National Cancer Institute. (2011-12-16)

Brachytherapy was associated with twofold increased risk for mastectomy, complications
Compared with women treated with whole-breast irradiation, women treated with brachytherapy experienced a twofold increased risk for losing their breasts, according to findings presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. (2011-12-06)

Study finds side effects, complications, mastectomy more likely after partial breast irradiation
Accelerated partial breast irradiation brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation, according to researchers from the University of Texas MD Anderson Cancer Center. (2011-12-06)

Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation
In a new study led by Fox Chase Cancer Center radiation oncologist Natasha Townsend, M.D., researchers have found that Gleason scores determined by pathologists at Fox Chase Cancer Center more accurately predict the risk of recurrence than Gleason scores from referring institutions. She presented the new research at the 53rd Annual Meeting of the American Society for Radiation Oncology on Monday, Oct. 3. (2011-10-04)

Candid discussion regarding sexuality can improve quality of life for prostate cancer survivors
Physicians are now better able to predict a man's recovery of sexual function after prostate cancer treatment, making a conversation between doctor and patient an important part of pre-treatment planning, a Beth Israel Deaconess Medical Center-led research team suggests. (2011-09-20)

Prediction models help determine likelihood of erectile function after treatment for prostate cancer
The development of prediction models that included variables such as pretreatment sexual function, patient characteristics and treatment factors appear to be effective at predicting erectile function two years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer, according to a study in the Sept. 21 issue of JAMA. (2011-09-20)

Researchers develop and test new molecule as a delivery vehicle to image and kill brain tumors
A single compound with dual function -- the ability to deliver a diagnostic and therapeutic agent -- may one day be used to enhance the diagnosis, imaging and treatment of brain tumors, according to findings from Virginia Commonwealth University and Virginia Tech. (2011-08-03)

Hormone therapy may be hazardous for men with heart conditions
Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk prostate cancer according to a new study just published online in advance of print in the International Journal of Radiation Oncology•Biology•Physics, the official scientific journal of ASTRO. (2011-07-26)

ASCO: Emerging trends in radiation therapy for women over 70 with early stage breast cancer
Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers. (2011-06-02)

ASTRO publishes evidence-based guideline for thoracic radiotherapy
The American Society for Radiation Oncology (ASTRO) has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO. (2011-04-27)

Brachytherapy, the official journal of ABS, expands to 6 issues in 2011
Elsevier, a world leader in health care and medical publishing and online solutions, today announced the significant expansion of scientific content to be published in Brachytherapy, the official journal of the American Brachytherapy Society. (2011-04-12)

BUSM study shows chemoradiotherapy prior to surgery improves survival
Researchers from Boston University School of Medicine have found that patients with node negative T3 and T4 non-small lung cancer who underwent chemotherapy before surgery had more than three times the survival rate than patients who only underwent surgery. (2011-02-28)

UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure to surrounding tissue and a shorter treatment period. (2011-02-15)

Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear
It remains an unresolved issue as to whether interstitial brachytherapy has advantages compared to other therapy options in men with localized prostate cancer, nor do newer studies provide proof in this respect. This is the result of a current IQWiG report, thereby confirming the conclusions of research already completed by the Institute in 2007. Studies of informative value are still lacking. (2011-01-11)

Active surveillance for low-risk prostate cancer may offer better quality-of-life
In a study that compared initial treatment strategies for low-risk prostate cancer among men 65 years old, active surveillance showed higher measures on quality of life compared to an initial treatment such as radical prostatectomy, although the optimal strategy was highly dependent on individual patient preferences for surveillance or treatment, according to a study in the Dec. 1 issue of JAMA. (2010-11-30)

New model may simplify high-dose radiosurgery planning
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers. Radiation oncology researchers at Ohio State University may have solved the problem with a new mathematical model called the Generalized LQ (gLQ) Model that encompasses all dose levels and schedules. (2010-09-02)

Researcher finds revolutionary way to treat eye cancer
A University of Colorado researcher recently discovered an eye cancer treatment that may prevent blindness. (2010-08-27)

NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer
NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells. (2010-07-27)

Radiation device allows for targeted breast radiation to control cancer
A new study of breast cancer patients at the Moores UCSD Cancer Center and the Arizona Oncology Services shows that after almost two years, the radiation given with the Strut-Adjusted Volume Implant (SAVI) controls the rate of cancer and may reduce the complications seen with alternate types of brachytherapy. (2010-07-12)

Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010
At the 52nd meeting of the American Association of Physicists in Medicine, which convenes from July 18-22, 2010 in Philadelphia, Pa., thousands of scientists and board-certified health professionals will gather to share the latest developments in medical imaging and radiation therapy, examine new clinical and laboratory data, and discuss many of the ethical and regulatory issues that face the field today. (2010-07-09)

Optimizing brachytherapy dose on the same day as the implant can control prostate cancer
Ensuring the optimum radiation dose on the same day as the brachytherapy implant in prostate cancer treatment manages to control the illness in about 95 percent of the cases. This is the result of research undertaken at the University Hospital of Navarre. (2010-06-23)

ASTRO patient education program recognized by AAA Awards
The American Society for Radiation Oncology has been named to the 2010 Associations Advance America Honor Roll for outstanding work on its public awareness campaign to help cancer patients and their families understand their treatment options. (2010-06-09)

The John Theurer Cancer Center recognizes medical physics team for safety track record
The John Theurer Cancer Center at Hackensack University Medical Center announced today that the Division of Radiation Oncology has recognized Joseph Hanley, Ph.D., director, medical physics, the John Theurer Cancer Center and his team for outstanding excellence in patient safety. The team was presented with an award for their exceptional work developing and maintaining Intensity-Modulated Radiation Therapy quality assurance. (2010-06-07)

ASTRO president speaks on prostate cancer at MEDCAC meeting
ASTRO President Anthony Zietman, M.D., spoke before the Medicare Evidence Development and Coverage Advisory Committee meeting today on radiation therapy for treatment of localized prostate cancer. MEDCAC provides advice and recommendations to the Centers for Medicare and Medicaid Services for what is covered by Medicare and Medicaid, based on scientific evidence. Today's meeting focused on the risks, benefits and outcomes of radiation therapy treatments for localized prostate cancer as compared with watchful waiting. (2010-04-21)

Apixaban more effective than enoxaparin in preventing thromboembolism after knee surgery
This release contains information on this week's studies appearing in the Lancet. (2010-03-04)

Sexual function does not continuously decline after radiation therapy treatments for prostate cancer
Sexual function in prostate cancer patients receiving external beam radiation therapy decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a study in the Jan. 1 issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of the American Society for Radiation Oncology. (2010-01-05)

Report suggests similar effectiveness among options for managing low-risk prostate cancer
A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably. The report was prepared by the Institute for Clinical and Economic Review, a leader in comparative effectiveness research based at the Massachusetts General Hospital's Institute for Technology Assessment. (2010-01-05)

3-week course of breast radiation may be as effective as conventional 5- to 7-week course for early breast cancers
According to a study presented Nov. 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology, a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant sides effects. (2009-11-04)

Task force develops new radiation guidelines for brachytherapy
Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analyzed using post-implant CT or MRI and uniformly documented in every patient, according to a new guideline co-authored by Yan Yu, Ph.D., director of medical physics in the department of radiation oncology at Thomas Jefferson University. (2009-11-02)

Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk
Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to a study in the Aug. 26 issue of JAMA. (2009-08-25)

Study shows seed implants a suitable prostate cancer treatment option for men of all ages
Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient. Trends among medical professionals have tipped the scales in favor of some treatments for younger men diagnosed with prostate cancer. The Feinstein Institute for Medical Research and North Shore-LIJ Health System have found that age doesn't make a difference in the long-term therapeutic outcome. (2009-08-03)

Prostate cancer patients disease free after 5 years likely to be disease free after 10 years
Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of the American Society for Radiation Oncology. (2009-07-02)

External beam partial breast irradiation most cost-effective treatment
External beam partial breast irradiation is the most cost-effective method for treating postmenopausal women with early stage breast cancer based on utilities, recurrence risks and costs when compared to whole breast radiotherapy and brachytherapy partial breast irradiation, according to a study in the June 1 issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of the American Society for Radiation Oncology. (2009-06-02)

Long-term study shows low oxygen levels in prostate tumors can predict recurrence
Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen levels, a marker of tumor recurrence in prostate cancer. (2009-05-15)

Radiation device in the breast reduces complications for early stage breast cancer patients
A new study shows that the SAVI applicator, a small, expandable device inserted inside the breast to deliver partial breast irradiation, carries a low infection risk, a potential complication of such devices. (2009-04-23)

Agent Orange exposure increases veterans' risk of aggressive recurrence of prostate cancer
Veterans exposed to Agent Orange are at increased risk of aggressive recurrence of prostate cancer, researchers report. (2009-04-20)

Page 3 of 6 | 224 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to